Jennifer Keppler

1.4k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Jennifer Keppler is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Jennifer Keppler has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiation. Recurrent topics in Jennifer Keppler's work include Radiopharmaceutical Chemistry and Applications (7 papers), Medical Imaging Techniques and Applications (5 papers) and Prostate Cancer Treatment and Research (5 papers). Jennifer Keppler is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Medical Imaging Techniques and Applications (5 papers) and Prostate Cancer Treatment and Research (5 papers). Jennifer Keppler collaborates with scholars based in United States. Jennifer Keppler's co-authors include Peter S. Conti, Chester A. Mathis, Stephanie Reeder, Richard J. Caselli, Howard Aizenstein, Napatkamon Ayutyanont, Daniel Bandy, Xiaofen Liu, William E. Klunk and Eric M. Reiman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and American Journal of Roentgenology.

In The Last Decade

Jennifer Keppler

13 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

2009 618 citations Eric M. Reiman, Kewei Chen et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jennifer Keppler

Since Specialization

Citations

This map shows the geographic impact of Jennifer Keppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Keppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Keppler more than expected).

Fields of papers citing papers by Jennifer Keppler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Keppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Keppler. The network helps show where Jennifer Keppler may publish in the future.

Co-authorship network of co-authors of Jennifer Keppler

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Keppler. A scholar is included among the top collaborators of Jennifer Keppler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Keppler. Jennifer Keppler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	First-in-Human Imaging with ⁸⁹Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake 2016 ·Journal of Nuclear Medicine ·Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Shutian Ruan, Serge K. Lyashchenko, Jorge A. Carrasquillo, Glenn Heller, Danny F. Martinez, Sarah M. Cheal, Jason S. Lewis, Martin Fleisher, Jennifer Keppler, Robert E. Reiter, Anna M. Wu, Wolfgang Weber, Howard I. Scher, Steven M. Larson, Michael J. Morris	106
2	A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with ⁸⁹Zr-Df-IAB2M in metastatic prostate cancer (PCa). 2016 ·Journal of Clinical Oncology ·Michael J. Morris, Danny F. Martinez, Jeremy C. Durack, Susan F. Slovin, Daniel C. Danila, (unknown), (unknown), Serge K. Lyashchenko, Jorge A. Carrasquillo, Shutian Ruan, Jason S. Lewis, Jennifer Keppler, Anna M. Wu, Victor E. Reuter, Wolfgang Weber, Howard I. Scher, Steven M. Larson, Neeta Pandit‐Taskar	3
3	First in Human 89Zr-Df-IAB2M anti-prostate specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer. 2015 ·Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Danny F. Martinez, Serge K. Lyashchenko, Jorge A. Carrasquillo, Jeremy C. Durack, Jennifer Keppler, Howard I. Scher, Steven M. Larson, Michael J. Morris	2
4	Pathologic correlation of ⁸⁹Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer. 2015 ·Journal of Clinical Oncology ·Michael J. Morris, Stephen B. Solomon, Jeremy C. Durack, (unknown), Serge K. Lyashchenko, Shutian Ruan, Jorge A. Carrasquillo, Jason S. Lewis, Danny F. Martinez, (unknown), Jennifer Keppler, Anna M. Wu, Victor E. Reuter, Wolfgang Weber, Howard I. Scher, Steven M. Larson, Neeta Pandit‐Taskar	1
5	Minibody imaging of prostate-specific membrane antigen (PSMA): From concept to clinic. 2014 ·Journal of Clinical Oncology ·Tove Olafsen, Derek W. Bartlett, David D. Ho, (unknown), Michael Torgov, Jennifer Keppler, Christian Behrenbruch, Anna M. Wu, Neeta Pandit‐Taskar, Michael J. Morris, Jason S. Lewis, Serge K. Lyashchenko, Jean Gudas	1
6	Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease breakdown → 2009 ·Proceedings of the National Academy of Sciences ·Eric M. Reiman, Kewei Chen, Xiaofen Liu, Daniel Bandy, Meixiang Yu, Wendy Lee, Napatkamon Ayutyanont, Jennifer Keppler, Stephanie Reeder, Jessica B. Langbaum, Gene E. Alexander, William E. Klunk, Chester A. Mathis, Julie C. Price, Howard Aizenstein, Steven T. DeKosky, Richard J. Caselli	618
7	A rational regulatory approach for positron emission tomography imaging probes: from ?first in man? to NDA approval and reimbursement 2004 ·Molecular Imaging and Biology ·Jorge R. Barrio, Craig B. Marcus, Jui‐Hsiang Hung, Jennifer Keppler	7
8	A Cost Analysis of Positron Emission Tomography 2001 ·American Journal of Roentgenology ·Jennifer Keppler, Peter S. Conti	35
9	Federal regulations and reimbursement for PET. 2001 ·PubMed ·Jennifer Keppler	9
10	The current status of positron emission tomography. 2000 ·PubMed ·W.M. Digby, Jennifer Keppler	7
11	Regulation of positron emission tomography: a case study. 1998 ·American Journal of Roentgenology ·Jennifer Keppler, (unknown), Peter S. Conti	4
12	PET and [18F]-FDG in oncology: A clinical update 1996 ·Nuclear Medicine and Biology ·Peter S. Conti, David L. Lilien, (unknown), Jennifer Keppler, Scott T. Grafton, James R. Bading	204
13	Positron emission tomography: a financial and operational analysis. 1994 ·American Journal of Roentgenology ·Peter S. Conti, Jennifer Keppler, J Halls	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact